Stockreport

Belite Bio Announces Availability of Annual Report on Form 20-F Through Company Website

Belite Bio, Inc - American Depositary Shares  (BLTE) 
PDF SAN DIEGO, March 31, 2026 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE), a clinical-stage development company focused on advancing novel therapeutics targeting de [Read more]